Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Features Joint therapy approved by the FDA for both intravenous and intra-articular use, allowing treatment tailored to the veterinarian's preference and the horse's individual needs Millions of doses sold 5 More than 25 years of treatment success Safe and effective, proven by multiple studies Reduces production of inflammatory mediators, joint inflammation and the resulting lameness for at least 45 days after being given once a week for three weeks 4 Benefits Safe and effective 90% of cases treated intravenously judged to have excellent to good overall clinical improvement 1 96% of horses treated intra-articularly were judged to have excellent to good overall clinical improvement 1 Improvement can be seen after one dose Breaks the cycle of inflammation and lameness associated with synovitis Stimulates endogenous hyaluronic acid production 2 Decreases the presence of inflammatory mediators 4 Easy to use I.V
Imagine you have a device that draws 60A peak
A DEXA scan is the most accurate way to monitor this crucial biomarker over time
Click on the button below to activate the discount code
As you incrementally increase the Ipamorelin dosage, you have the opportunity to closely monitor your progress and any changes in your body's response
Genetic Variation in GAD1 Is Associated with Cortical Thickness in the Parahippocampal Gyrus. Journal of Psychiatric Research, vol
